JOURNAL of
ONCOLOGICAL
SCIENCES

Similar Articles




  • Reflexology and cancer a Cay State Hospital, Ministry of Health, Afyonkarahisar, Turkey b Memorial Antalya Hospital, Oncology Department, Antalya, Turkey DOI: 10.1016/j.jons.2018.01.001 Sayfalar: 96 - 101 1329 Viewed.


  • Angiogenesis inhibition on glioblastoma multiforme cell lines (U-87 MG and T98G) by AT-101 aDivision of Medical Oncology, Department of Internal Medicine, Tulay Aktas Oncology Hospital, Ege University School of Medicine, Izmir, Turkey bFethiye State Hospital Oncology Unit, Fethiye, Turkey cSection of Molecular Biology, Department of Biology, Faculty of Science and Letters, Manisa Celal Bayar University, Manisa, Turkey DOI: 10.1016/j.jons.2018.06.002 Sayfalar: 65 - 69 849 Viewed.

  • A retrospective study on potential drug interactions: A single center experience a Trakya University Health Center for Medical Research and Practice, Edirne, Turkey b Faculty of Medicine, Trakya University, Turkey c Department of Medical Oncology, Faculty of Medicine, Trakya University, Turkey DOI: 10.1016/j.jons.2018.06.001 Sayfalar: 80 - 84 1378 Viewed.


  • Is there an association between CRP levels and tumor size in breast cancer patients? a Beykent University, Faculty of Medicine, Istanbul, Turkey b Department of Medical Oncology, Private Tınaztepe Hospital, Izmir, Turkey c Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaras, Turkey d MKA Breast Cancer Clinic, Ankara, Turkey DOI: 10.1016/j.jons.2017.08.004 Sayfalar: 106 - 107 850 Viewed.

  • Lymphocytic thyroiditis simulating thyroid cancer biochemically, radiologically and pathologically a Kocaeli University, Faculty of Medicine, Department of Oncology, Kocaeli, Turkey b Cukurova University, Faculty of Medicine, Department of Oncology, Kocaeli, Turkey c Ataturk University, Faculty of Medicine, Department of Oncology, Kocaeli, Turkey d Cukurova University, Faculty of Medicine, Department of Nuclear Medicine, Kocaeli, Turkey e Cukurova University, Faculty of Medicine, Department of Pathology, Kocaeli, Turkey DOI: 10.1016/j.jons.2018.04.003 Sayfalar: 114 - 115 732 Viewed.




  • Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients a Health Sciences University, Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey b Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey c Ege University, Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey d Medipol Mega Hospitals Complex, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey e Sakarya University, Faculty of Medicine, Department of Medical Oncology, Sakarya, Turkey f Akdeniz University, Faculty of Medicine, Department of Medical Oncology, Antalya, Turkey g Pamukkale University, Faculty of Medicine, Department of Medical Oncology, Denizli, Turkey h Ondokuz Mayıs University, Faculty of Medicine, Department of Medical Oncology, Samsun, Turkey i Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey j Baskent University Faculty of Medicine, Department of Medical Oncology, Adana, Turkey k Medical Science Liaison, Bristol Myers Squib, Istanbul, Turkey l Istanbul Cerrahpasa University, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey m Dicle University, Faculty of Medicine, Department of Medical Oncology, Diyarbakır, Turkey n MarmaraUniversity, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey oUniversity of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey p Medical Park Tarsus Hospital, Department of Medical Oncology, Mersin, Turkey qMedical Park Samsun Hospital, Department of Medical Oncology, Samsun, Turkey rGazi University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey sAcıbadem University, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey DOI: 10.1016/j.jons.2018.10.001 Sayfalar: 125 - 129 1047 Viewed.